Monographie - Insulin lyspro

Ultimo aggiornamento :
08/05/2024

Insulin lyspro

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Humalog

Africa del Sud, Arabia Saudita, Argentina, Austria, Belgio, Canada, Chile, Colombia, Croazia, Danimarca, Ecuador, Finlandia, Francia, Germania, Giappone, Gran Bretagna, Grecia, Irlanda, Islanda, Italia, Lussemburgo, Malaysia, Marocco, Messico, Norvegia, Paesi Bassi, Polonia, Portogallo, Romania, Slovenia, Spagna, Stati Uniti d’America, Svezia, Svizzera, Turchia, Ungheria, Venezuela

Bibliografia : Insulin lyspro

	Tipo	Pubblicazione
2269	Rivista	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3149	Rivista	DeFelippis MR, Bell MA, Heyob JA, Storms SM. In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion. Diabetes Tech and Ther 2006 ; 8, 3: 358-368.
3249	Rivista	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
4433	Rivista	Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K. Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications Clin Ther 2020 ; 42, 3: 475-485.
4650	Laboratorio	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021

Mentions Légales